Open AccessDual HER2 blockade with lapatinib and trastuzumab in combination with chemotherapy in metastatic gastroesophageal adenocarcinoma
Author(s) -
Cheong E. Von,
Ho Gwo Fuang
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4009
Subject(s) - lapatinib , trastuzumab , medicine , blockade , oncology , chemotherapy , cancer , breast cancer , receptor
The development of resistance to trastuzumab in HER2‐positive gastroesophageal cancer remains a problem. The use of dual HER2 blockade to overcome this is a therapeutic strategy that should be researched more extensively.